BIOMAT Database Logo BIOMAT Database Logo

Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. 1999

S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

It has been shown in previous studies that a variety of estrogen receptor (ER) beta mRNA transcripts are expressed in human breast cancer cell lines and tumors. To complement the RNA expression studies, we have developed ER-beta-specific antibodies to characterize ER-beta protein expression in breast cancer cell lines and tumors. Monoclonal antibodies were made against a peptide representing the first 18 amino acids of the longest ER-beta open reading frame reported to date, and polyclonal antibodies were made against a peptide within the ER-beta B domain. By Western blot analysis, we show that ER-beta protein is expressed in all cancer cell lines tested and in three of five breast tumor samples. The breast cancer cell lines showed variation in the size of the expressed ER-beta protein. The longest form detected was consistent with the 530-amino acid, full-length ER-beta sequence. Shorter ER-beta isoforms were detected in the ER-alpha-negative MDA-MB-231 and MDA-MB-435 breast cancer cell lines, likely corresponding to previously described COOH-terminal RNA variant isoforms.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D047629 Estrogen Receptor beta One of the ESTROGEN RECEPTORS that has greater affinity for ISOFLAVONES than ESTROGEN RECEPTOR ALPHA does. There is great sequence homology with ER alpha in the DNA-binding domain but not in the ligand binding and hinge domains. ERbeta,ERbetacx,Estrogen Receptor 2,Estrogen Receptors beta,Receptor beta, Estrogen

Related Publications

S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Differential expression of estrogen receptor beta isoforms in human breast cancer tissue.
January 2003, Anticancer research,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
February 2001, Cancer letters,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
February 2002, Breast cancer research and treatment,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.
November 2007, Japanese journal of clinical oncology,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Expression of estrogen receptor beta messenger RNA variant in breast cancer.
January 1998, Cancer research,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.
August 2006, Pathology international,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
December 1993, Cancer research,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Clinical importance of estrogen receptor beta isoforms in breast cancer.
December 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
[Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].
August 2005, Zentralblatt fur Gynakologie,
S A Fuqua, and R Schiff, and I Parra, and W E Friedrichs, and J L Su, and D D McKee, and K Slentz-Kesler, and L B Moore, and T M Willson, and J T Moore
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
May 1997, The American journal of pathology,
Copied contents to your clipboard!